Literature DB >> 15616645

Angiogenesis and stroke.

D A Greenberg1.   

Abstract

Stroke results from focal cerebral ischemia due to occlusion of a cerebral blood vessel, usually an artery. Where ischemia is chronic or intermittent, collateral circulation may develop by enlargement of preexisting anastomotic channels or sprouting of new capillaries from existing vessels (angiogenesis). Angiogenesis has three attributes of particular interest in relation to cerebral vascular disease: 1) it is the principal mechanism by which the brain is vascularized; 2) unlike vasculogenesis, it continues in adulthood; and 3) as in other tissues, it can be induced in the CNS by hypoxia or ischemia. Vascular endothelial growth factor (VEGF) is a key mediator of angiogenesis. The angiopoietins, Ang-1 and Ang-2, and their common receptor, Tie-2 or Tek, constitute another signaling system that regulates angiogenesis, and which interacts with VEGF. Four recent studies provide evidence for the induction of angiogenesis, VEGF and VEGF receptor expression in experimental models of cerebral ischemia. Further understanding of the role of VEGF, VEGF receptors and angiogenesis in the brain's response to ischemia may have implications for prognosis and treatment in stroke. (c) 1998 Prous Science. All rights reserved.

Entities:  

Year:  1998        PMID: 15616645     DOI: 10.1358/dnp.1998.11.5.657287

Source DB:  PubMed          Journal:  Drug News Perspect        ISSN: 0214-0934


  12 in total

1.  Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia.

Authors:  H J Marti; M Bernaudin; A Bellail; H Schoch; M Euler; E Petit; W Risau
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  Ischemia-induced Angiogenesis is Attenuated in Aged Rats.

Authors:  Yaohui Tang; Liuqing Wang; Jixian Wang; Xiaojie Lin; Yongting Wang; Kunlin Jin; Guo-Yuan Yang
Journal:  Aging Dis       Date:  2015-11-25       Impact factor: 6.745

3.  Noninvasive detection of neural progenitor cells in living brains by MRI.

Authors:  Christina H Liu; Jia Q Ren; Zerong You; Jinsheng Yang; Charng-Ming Liu; Ritika Uppal; Philip K Liu
Journal:  FASEB J       Date:  2011-12-23       Impact factor: 5.191

4.  Neural stem cell protects aged rat brain from ischemia-reperfusion injury through neurogenesis and angiogenesis.

Authors:  Yaohui Tang; Jixian Wang; Xiaojie Lin; Liuqing Wang; Bei Shao; Kunlin Jin; Yongting Wang; Guo-Yuan Yang
Journal:  J Cereb Blood Flow Metab       Date:  2014-04-09       Impact factor: 6.200

Review 5.  Delayed thrombosis of a complex fusiform ICA aneurysm treated with flow reversal and partial occlusion: case report and brief review of possible mechanisms.

Authors:  H Hakan Oruckaptan; H Saruhan Cekirge
Journal:  Neuroradiology       Date:  2010-11-16       Impact factor: 2.804

Review 6.  Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications.

Authors:  J Marc Simard; Thomas A Kent; Mingkui Chen; Kirill V Tarasov; Volodymyr Gerzanich
Journal:  Lancet Neurol       Date:  2007-03       Impact factor: 44.182

Review 7.  Marrow stromal cell transplantation in stroke and traumatic brain injury.

Authors:  Yi Li; Michael Chopp
Journal:  Neurosci Lett       Date:  2009-01-17       Impact factor: 3.046

Review 8.  Age-related changes in brain support cells: Implications for stroke severity.

Authors:  Farida Sohrabji; Shameena Bake; Danielle K Lewis
Journal:  Neurochem Int       Date:  2013-06-28       Impact factor: 3.921

9.  Two-photon imaging of cortical surface microvessels reveals a robust redistribution in blood flow after vascular occlusion.

Authors:  Chris B Schaffer; Beth Friedman; Nozomi Nishimura; Lee F Schroeder; Philbert S Tsai; Ford F Ebner; Patrick D Lyden; David Kleinfeld
Journal:  PLoS Biol       Date:  2006-01-03       Impact factor: 8.029

10.  Evidence for neuroprotective properties of human umbilical cord blood cells after neuronal hypoxia in vitro.

Authors:  Susann Hau; Doreen M Reich; Markus Scholz; Wilfried Naumann; Frank Emmrich; Manja Kamprad; Johannes Boltze
Journal:  BMC Neurosci       Date:  2008-02-29       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.